Stanford University

Medical Center

APBI Trial

Patient selection overview
Over the past decade several clinical trials have demonstrated that proper patient selection are important for the success of accelerated partial breast irradiation.  Criteria for Stanford’s clinical trial are:

Inclusion criteria:

age >= 40

tumor size <= 2.5 cm;

tumor type:  invasive ductal carcinoma or ductal carcinoma in situ

Exclusion criteria:

prior breast radiotherapy

breast implants

multi-focal or multicentric tumors

invasive lobular carcinoma

please call for additional questions

Contact Webmaster@apbitrial.org with comments or questions regarding this site. 
© Copyright Stanford University, www.apbitrial.org All rights reserved.